"We are delighted to participate in this important scientific conference and to highlight additional clinical evidence from our Expanded Access Program supporting the ability of MAT2203 to safely and ...
DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment ...
Amphastar Pharmaceuticals (NASDAQ:AMPH) presented its corporate overview on February 26, 2026, outlining an ambitious transformation toward proprietary and biosimilar products even as the company ...
AGOURA HILLS, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results